Supply Chain/Technology

Latest Issue of OR Manager
May 2025
Home Supply Chain/Technology

FDA: Class I recall of Arrow International’s Arrow-Trerotola PTD

Editor's Note The Food and Drug Administration (FDA) on February 23 identified the recall by Arrow International (Reading, Pennsylvania), a subsidiary of Teleflex Inc, of its Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) as Class I, the most serious. The recall was initiated because of the risk of tip damage during use…

Read More

By: Judy Mathias
February 24, 2022
Share

FDA: Class I recall of Vyaire Medical’s Bellavista Ventilators

Editor's Note The Food and Drug Administration (FDA) on February 17 identified the recall by Vyaire Medical (Mettawa, Illinois) of its Bellavista 1000 and 1000e Series Ventilators as Class I, the most serious. The recall was initiated because of issues with the software version 6.0.1600.0 or higher, after reports of…

Read More

By: Judy Mathias
February 24, 2022
Share

FDA: Class I recall of BASE10 Genetics RNAstill MTM specimen collection kits

Editor's Note The Food and Drug Administration (FDA) on February 18 identified the recall by BASE10 Genetics of its RNAstill MTM specimen collection kits as Class I, the most serious. The specimen collection kits are intended for collection, transport, inactivation, stabilization, and long-term storage of nasopharyngeal or oropharyngeal swab samples…

Read More

By: Judy Mathias
February 23, 2022
Share

FDA: Class I recall of E25Bio COVID-19 Direct Antigen Rapid Tests

Editor's Note The Food and Drug Administration (FDA) on February 18 identified the recall by E25Bio (Cambridge, Massachusetts) of its COVID-19 Direct Antigen Rapid Tests as Class I, the most serious. The tests are being recalled for several reasons, particularly because they were marketed and distributed in the US without…

Read More

By: Judy Mathias
February 22, 2022
Share

Sponsored Message

The Joint Commission issues Quick Safety on instrument reprocessing

Editor's Note The Joint Commission on February 14 issued a new Quick Safety on “Ensuring critical instruments and devises are appropriate for reuse.” The Quick Safety highlights reprocessing guidance from the Food and Drug Administration (FDA) as well as special considerations for single use devices reprocessed by third parties that…

Read More

By: Judy Mathias
February 16, 2022
Share

Effectiveness of reprocessing ureteroscopes, other endoscopic devices

Each year, there are more studies raising concerns about infections associated with endoscopic procedures and the techniques used to clean and sterilize or high-level disinfect (HLD) endoscopic devices. In this article, in partnership with Boston Scientific, epidemiologist Cori L. Ofstead, MSPH, president and CEO of Ofstead & Associates, St Paul,…

Read More

By: Judith M. Mathias, MA, RN
February 16, 2022
Share

Sponsored Message

Acclimating to OR, sterile processing department cultures

The differences between sterile processing (SP) and OR tasks and department cultures are significant. However, they share a collective goal: both work toward the best outcome for every patient. Still, both departments often suffer from having unrealistic goals for each other. One example is that the OR may expect instruments…

Read More

By: Angela Lewellyn, LPN, CRCST, CER, CHL
February 16, 2022
Share

New inhaled vaccine delivers broad protection against COVID-19, variants

Editor's Note In this study, Canadian researchers at McMaster University (Hamilton, Ontario) confirm that their newly developed inhaled form of COVID-19 vaccine provides long-lasting protection against the original strain of SARS-Cov-2 and variants of concern. The researchers compared two types of adenovirus platforms for the vaccine. The adenoviruses serve as…

Read More

By: Judy Mathias
February 10, 2022
Share

Amazon expands telehealth services

Editor's Note Amazon announced on February 8 that it is expanding its telehealth service, Amazon Care, nationwide. Previously, it was available only to employees and their families in and around its Seattle headquarters. Amazon also is expanding its in-person care services to more than 20 new cities this year. When…

Read More

By: Judy Mathias
February 10, 2022
Share

FDA: Class I recall of Empowered Diagnostics COVID-19 tests

Editor's Note The Food and Drug Administration (FDA) on January 28 identified the recall by Empowered Diagnostics (Pompano Beach, Florida) of its CovClear COVID-19 Rapid Antigen Test and ImmunoPass COVID-19 Neutralizing Antibody Rapid Test as Class I, the most serious. Empowered Diagnostics distributed these tests with labeling indicating they were…

Read More

By: Judy Mathias
February 8, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat